Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study

Abstract Background Monogenic autoinflammatory diseases (AIDs) are rare inflammatory diseases caused by genetic variants. The pathogenesis is complex and treatment options are limited. This study aimed to describe the safety and efficacy of thalidomide in the treatment of monogenic AIDs. Methods Thi...

詳細記述

書誌詳細

主要な著者:	Caihui Zhang, Zhongxun Yu, Sihao Gao, Mingsheng Ma, Lijuan Gou, Changyan Wang, Lin Wang, Ji Li, Linqing Zhong, Yu Zhou, Wei Wang, Hongmei Song
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2023-10-01
シリーズ:	Pediatric Rheumatology Online Journal
主題:	Thalidomide Monogenic autoinflammatory disease Efficacy Safety
オンライン･アクセス:	https://doi.org/10.1186/s12969-023-00881-0
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!